Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, FN Staphylococcus aureus

Details for Australian Patent Application No. 2005276144 (hide)

Owner The University of Western Ontario

Inventors Dale, Suzanne; Heinrichs, David E.

Agent Shelston IP

Pub. Number AU-B-2005276144

PCT Pub. Number WO2006/021893

Priority 60/604,769 26.08.04 US

Filing date 26 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 5 August 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12Q 1/18 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Testing for antimicrobial activity of a material

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/021893 Priority application(s): WO2006/021893

5 August 2010 Application Accepted

  Published as AU-B-2005276144

2 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005276145-Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells

2005276136-Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates